key: cord-0712690-2ph0rfjc
authors: Lin, Xinwen; Twelkmeyer, Trix; Wang, Si-Yu; Xu, Ruo-Nan; Wang, Fu-Sheng; Zhang, Chao; Tang, Hong
title: An immunopathogenic perspective of interleukin-1 signaling
date: 2020-05-28
journal: Cell Mol Immunol
DOI: 10.1038/s41423-020-0475-y
sha: a4e75bb1ada5d035c405892510a5c4a106751695
doc_id: 712690
cord_uid: 2ph0rfjc

nan

Interleukin-1 (IL-1), referred to as two distinct proteins, IL-1α and IL-1β, was first described almost 50 years ago. 1 IL-1α and IL-1β represent immediate early innate cytokines critically involved in alarming and activating the host defense system. 2 Therefore, any impairment of IL-1 signaling pathways often leads to devastating outcomes, such as autoimmunity and autoinflammation, dysmetabolism, cardiovascular disorders, and cancer. 2 Many advances in targeting IL-1 in immune therapies have been achieved; for example, the IL-1-blocking agents anakinra (IL-1 receptor antagonist, IL-1Ra), canakinumab (anti-IL-1β mAb), and MABp1 (anti-IL-1α mAb) have been approved for clinical use or are being evaluated. 2 Remarkably, the CANTOS study, which included over 10,000 patients, showed that blocking IL-1β not only reduced atherosclerosis-related cardiovascular mortality but was also effective in inflammatory diseases related to lung cancer, arthrosis, and gout. 3 Nevertheless, because of the specific spatiotemporal expression pattern of IL-1 and the complex regulatory networks of IL-1related pathways, it is still not fully understood how exactly IL-1 functions, and how to precisely rectify dysfunctional IL-1 signaling during diverse inflammatory conditions remains unknown.

For a long time, IL-1α and IL-1β, albeit sharing limited sequence homology, were considered redundant. They share similar threedimensional structures and interact with the same receptor, a heterodimer composed of IL-1R1 and IL-1R accessory protein (IL-1Rap), to initiate the NF-κB signal transduction cascade. However, strong evidence is accumulating that IL-1α and IL-1β each play specific roles in different pathological conditions (Table 1) . For example, it was reported that neutrophil recruitment induced by necrotic cells is likely dependent on IL-1α but not IL-1β. 4 The preferential usage of IL-1α over IL-1β for activating IL-1R1 has also been confirmed in other studies, including studies in druginduced liver injury (DILI), 5 fatty acid-induced vascular response and atherosclerosis, 6 and autoimmune disease. 7 In a dextran sulfate sodium (DSS)-induced colitis mouse model, IL-1α from the intestinal epithelium drives intestinal inflammation, whereas IL-1β acts to heal the intestinal epithelial barrier. 8 Moreover, in murine neonatal sepsis, IL-1α but not IL-1β accounts for morbidity and mortality. 9 IL-1α signaling is also critical in leukocyte recruitment and pulmonary inflammation in response to Aspergillus fumigatus 10 and Legionella pneumophila infection. 11 IL-1α and IL-1β differ from each other in gene expression and posttranslational modification. IL-1α precursor protein is expressed and preserved in a wild variety of mesenchymal cells, including keratinocytes, epithelial cells of the lung and entire gastrointestinal tract, and brain astrocytes. 12 In contrast, the IL-1β precursor is an inducible factor produced mainly by myeloid cells after TLR signaling is activated. 12 Furthermore, the IL-1α precursor is fully active, and upon direct release from damaged cells, it functions as an alarmin to initiate the inflammatory response. IL-1α precursor protein can also be cleaved by an array of different proteases, such as granzyme B, elastase, and calpain-1, leading to drastically enhanced bioactivity. The inactive IL-1β precursor, on the other hand, can be cleaved by inflammasome-activated caspase-1 and released via a tightly controlled GSDMD pore to the extracellular matrix. 13 It is worth noting that most studies on inflammasomes or IL-1β do not exclude the potential involvement of IL-1α, especially considering that inflammasomal activation also facilitates IL-1α secretion. 14 The understanding of IL-1α and IL-1β is also complicated due to their shared usage of IL-1R1, which uses MyD88 as an adaptor in the pro-inflammatory NF-κB signaling pathway. IL-1R1 signal specificity may be based on the IL-1R1-expressing cell type and associated IL-1 stimulation from neighboring cells. In a mouse model of DILI, the expression of IL-1R1 is mainly restricted to myeloid cells among hepatic lymphocytes. In one study, IL-1α made by macrophages activated neutrophils via a paracrine loop and promoted hepatic injury during the early phase of DILI. 5 In another study, liver cells lacking IL-1R1 resisted cell death but were dependent on neighboring cells, arguing for the involvement of IL-1 from these cells. 15 The involvement of IL-1 in distinct immunological, neural, and physiological activities in the brain has recently been revealed in vivo, and it depended on different cell type-specific IL-1R1 signaling pathways. Liu et al. employed genetic knock-in reporter mice to track and reciprocally delete and/or express IL-1R1 in specific CNS cell types, including endothelial cells, ventricular cells, peripheral myeloid cells, microglia, astrocytes, and neurons. Particularly, they demonstrated that endothelial IL-1R1-driven leukocyte recruitment to the central nervous system accounted for impaired neurogenesis; ventricular IL-1R1 regulated monocyte recruitment; and noninflammatory ventricular, astrocyte, and neuronal IL-1R1-mediated neuromodulatory activities. 16, 17 In addition, IL-1 is also a licensing signal to permit effector cytokine production by precommitted T helper lineage cells, including Th1, Th2, and Th17 cells. IL-1R signaling stabilizes cytokine transcripts to enable productive and rapid effector functions in CD4+ T cells. 18 Moreover, the pathogenetic roles of GM-CSF-secreting Th cells have been reported in central nervous system inflammation, 19 sepsis, 20 and the recently reported COVID-19. 21 IL-1R signaling is required for the maintenance and pathogenicity of GM-CSF-producing Th cells. 22 Specifying the cell sources and magnitude of IL-1α and IL-1β signaling through the shared IL-1R1 is critical to understanding CD4+ T helper functions.

The therapeutic activities of anti-IL-1 antibodies across diseases argue for innate inflammatory response as a metanarrative in modern medicine. More efforts are needed to clarify the roles of IL-1/IL-1R1 signaling and effectors to better understand the immunopathogenesis of diseases and improve current targeted treatments.

Competing interests: The authors declare no competing interests.

Zhang et al. 5 DILI Macrophage IL-1α, rather than IL-1β, was critically involved in the immunopathogenesis of AILI. Activation of IL-1α depended on Kupffer cells that sense and transduce DAMP signaling through the TLR4/MyD88 pathway.

Freigang et al. 6 Atherosclerosis Vascular cells Fatty acids selectively stimulated the release of IL-1α but not of IL-1β by uncoupling mitochondrial respiration.

Lukens et al. 7 Autoinflammation Hematopoietic cells IL-1α, but not IL-1β or RIP3-mediated necroptosis, was critical for exacerbated inflammatory responses and unremitting tissue damage upon footpad microabrasion of Ptpn6 spin mice.

Bersudsky et al. 8 

Intestinal epithelial cells (IECs)

The roles of IL-1α and IL-1β differed in DSS-induced colitis in that IL-1α, mainly expressed by colon epithelial cells, was inflammatory, whereas IL-1β, mainly of myeloid cell origin, promoted healing and repair.

Benjamin et al. 9 Sepsis NA IL-1α, but not IL-1β, mediated the detrimental effects of IL-1R1 signaling on neonatal sepsis survival.

Caffrey et al. 10 Aspergillus fumigatus infection NA IL-1α played an important role in orchestrating the optimal recruitment of neutrophils and monocytes, whereas IL-1β and the inflammasome were more important in the activation of the antifungal activity of monocytes.

Barry et al. 11 Legionella pneumophila infection Hematopoietic cells IL-1α was a critical initiator of neutrophil recruitment to the lungs of L. pneumophila-infected mice.

An immunopathogenic perspective of interleukin-1 signaling X Lin et al.

Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factors

Interleukin-1 and related cytokines in the regulation of inflammation and immunity

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

Macrophage-derived IL-1alpha promotes sterile inflammation in a mouse model of acetaminophen hepatotoxicity

Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1alpha and sterile vascular inflammation in atherosclerosis

RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3

Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice

Cutting Edge: IL-1α and not IL-1β drives IL-1R1-dependent neonatal murine sepsis lethality

IL-1alpha signaling is critical for leukocyte recruitment after pulmonary Aspergillus fumigatus challenge

IL-1α signaling initiates the inflammatory response to virulent Legionella pneumophila in vivo

Function and regulation of IL-1alpha in inflammatory diseases and cancer

The gasdermins, a protein family executing cell death and inflammation

Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1

Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation

Cell-type-specific interleukin 1 receptor 1 signaling in the brain regulates distinct neuroimmune activities

Mapping IL-1 in the brain

T cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T cells

Foxo3 transcription factor drives pathogenic T helper 1 differentiation by inducing the expression of eomes

High levels of circulating GM-CSF+ CD4+ T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study

Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients

Fate-mapping of GM-CSF expression identifies a discrete subset of inflammation-driving T helper cells regulated by cytokines IL-23 and IL-1β

Macrophage Cell death-triggered inflammation required IL-1α, and IL-1R function on non-bone marrow-derived cells was required